The State of Myeloproliferative Neoplasms (MPNs) - Episode 7
Focusing on clinical trials and novel therapies, Rami Komrokji, MD, and Ruben Mesa, MD, share their hope for the future management of essential thrombocythemia and polycythemia vera.
Related Content:
Ceralasertib-Imfinzi Misses Survival End Point in Lung Cancer Trial
Cognitive Health Gains Focus in Kidney Cancer Survivorship
One More Christmas: How Cancer Changed How I Experience the Holidays
Trodelvy Shows Fewer Side Effects Than Chemotherapy in Some With TNBC